# Safety and Effectiveness Study of SQ-Kyrin TMVr System for Functional Mitral Regurgitation

Study · id `cardio:ct-nct05988450` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05988450](<https://clinicaltrials.gov/study/NCT05988450>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05988450

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 125 participants.

## Technical summary

Registry record NCT05988450. Allocation not applicable; no masking; primary purpose treatment. Start 2022-03-07 (actual); primary completion 2023-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 125 participants (enrolled count; ClinicalTrials.gov record NCT05988450, source copy `cardio:ctgov-nct05988450-2023-08-14`, retrieved 2026-10-26)
- Started: 2022-03-07 (actual) (ClinicalTrials.gov record NCT05988450, source copy `cardio:ctgov-nct05988450-2023-08-14`, retrieved 2026-10-26)
- Primary completion: 2023-12 (anticipated) (ClinicalTrials.gov record NCT05988450, source copy `cardio:ctgov-nct05988450-2023-08-14`, retrieved 2026-10-26)
- Completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT05988450, source copy `cardio:ctgov-nct05988450-2023-08-14`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05988450, source copy `cardio:ctgov-nct05988450-2023-08-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05988450-2023-08-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Effectiveness Study of SQ-Kyrin TMVr System for Functional Mitral Regurgitation
- Condition: Functional Mitral Regurgitation
- Intervention (Device): SQ-Kyrin Transcatheter Mitral Valve Repair System
- Lead sponsor: Shanghai Shenqi Medical Technology Co., Ltd
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry lists this organization as the lead sponsor: Shanghai Shenqi Medical Technology Co., Ltd (`cardio:org-shanghai-shenqi-medical-technology-co-ltd`)

## Provenance

Content hash: 5d8c157b6df2745859cacf089a9aa1611e3aa47c2e0b014294f67925fca35795
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
